SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001607062-19-000369
Filing Date
2019-09-24
Accepted
2019-09-24 16:33:07
Documents
7
Period of Report
2019-09-24
Effectiveness Date
2019-09-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A gnbt092119def14a.htm DEF 14A 314010
2 GRAPHIC image_001.gif GRAPHIC 2363
3 GRAPHIC image_002.gif GRAPHIC 18861
4 GRAPHIC image_003.gif GRAPHIC 30673
5 GRAPHIC image_004.gif GRAPHIC 9809
6 GRAPHIC image_005.gif GRAPHIC 30047
7 GRAPHIC image_006.gif GRAPHIC 25391
  Complete submission text file 0001607062-19-000369.txt   476370
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 191111169
SIC: 2834 Pharmaceutical Preparations